Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Seasonal Affective Disorder (SAD) affects millions of Americans, and cases usually start to rise in late fall or early winter ...

Results: We found that the relative risk of developing a depressive disorder was incidence rate ... in addition to treatment, be an effective way to delay or prevent the onset of depressive ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

Bright light therapy, a standard treatment for seasonal depression, may also help people who experience depression year-round ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can ...